Mayne Pharma Group Ltd (MAYNF)
4.26
-0.22
(-4.91%)
USD |
OTCM |
May 17, 16:00
Mayne Pharma Group Total Assets (Quarterly): 785.30M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 785.30M |
| June 30, 2023 | 825.66M |
| December 31, 2022 | 1.016B |
| June 30, 2022 | 885.98M |
| December 31, 2021 | 1.064B |
| June 30, 2021 | 1.099B |
| December 31, 2020 | 1.143B |
| June 30, 2020 | 1.254B |
| December 31, 2019 | 1.308B |
| June 30, 2019 | 1.146B |
| December 31, 2018 | 1.418B |
| June 30, 2018 | 1.345B |
| December 31, 2017 | 1.349B |
| June 30, 2017 | 1.472B |
| December 31, 2016 | 1.409B |
| June 30, 2016 | 1.163B |
| December 31, 2015 | 437.74M |
| June 30, 2015 | 405.70M |
| Date | Value |
|---|---|
| December 31, 2014 | 261.75M |
| June 30, 2014 | 250.27M |
| December 31, 2013 | 228.88M |
| June 30, 2013 | 216.56M |
| December 31, 2012 | 197.04M |
| June 30, 2012 | 54.11M |
| December 31, 2011 | 56.17M |
| June 30, 2011 | 57.37M |
| December 31, 2010 | 64.75M |
| June 30, 2010 | 59.84M |
| December 31, 2009 | 54.42M |
| June 30, 2009 | 6.476M |
| December 31, 2008 | 6.70M |
| June 30, 2008 | 11.20M |
| December 31, 2007 | 11.74M |
| June 30, 2007 | 13.15M |
| December 31, 2006 | 12.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
785.30M
Minimum
Dec 2023
1.308B
Maximum
Dec 2019
1.053B
Average
1.082B
Median
Total Assets (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 28.76M |
| Kazia Therapeutics Ltd | 16.61M |
| Immutep Ltd | 32.02M |
| Opthea Ltd | 166.50M |
| Mesoblast Ltd | 669.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 412.10M |
| Shareholders Equity (Quarterly) | 373.20M |
| Debt to Equity Ratio | 0.0668 |
| Current Ratio | 1.608 |
| Net Debt Paydown Yield | 24.51% |